Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study

Autor: Alparaque, Maricel, Anid, Liisa, Barnes, Eleanor, Benamore, Rachel, Bharti, Neha, Patel, Bhumika, Burns, Adrian, Byard, Nicholas, Conway, Oliver, Cooper, Cushla, Crowther, Charlotte, Dunachie, Susanna J, Johnstone, Trudi, Jose, Jyolsna, Luciw, Michael, Mujadidi, Yama, Nehiweze, Aiseosa, Nyamunda, Sibongile, Orobiyi-Rieba, Maria, Parvelikudy, Bindu, Platt, Abigail, Pswarayi, Dzikamayi, Quaddy, Jack, Samuel, Binnie Elizabeth, Sette, Alessandro, Sodipo, Victoria, Srijith, Preethu, Stone, Helen, Turner, Cheryl, Valmores, Mary Ann, Voaides, Alexandru, Vuddamalay, Gavindren, Jackson, Susan, Marshall, Julia L, Mawer, Andrew, Lopez-Ramon, Raquel, Harris, Stephanie A, Satti, Iman, Hughes, Eileen, Preston-Jones, Hannah, Cabrera Puig, Ingrid, Longet, Stephanie, Tipton, Tom, Laidlaw, Stephen, Doherty, Rebecca Powell, Morrison, Hazel, Mitchell, Robert, Tanner, Rachel, Ateere, Alberta, Stylianou, Elena, Wu, Meng-San, Fredsgaard-Jones, Timothy P W, Breuer, Judith, Rapeport, Garth, Ferreira, Vanessa M, Gleeson, Fergus, Pollard, Andrew J, Carroll, Miles, Catchpole, Andrew, Chiu, Christopher, McShane, Helen

Publikováno v: In The Lancet Microbe July 2024 5(7):655-668